Cargando…

Oncolytic viruses as therapeutic cancer vaccines

Oncolytic viruses (OVs) are tumor-selective, multi-mechanistic antitumor agents. They kill infected cancer and associated endothelial cells via direct oncolysis, and uninfected cells via tumor vasculature targeting and bystander effect. Multimodal immunogenic cell death (ICD) together with autophagy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartlett, David L, Liu, Zuqiang, Sathaiah, Magesh, Ravindranathan, Roshni, Guo, Zongbi, He, Yukai, Guo, Zong Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ https://www.ncbi.nlm.nih.gov/pubmed/24020520 http://dx.doi.org/10.1186/1476-4598-12-103

Ejemplares similares

Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
por: Francis, Lily, et al.
Publicado: (2016)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2017)

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer
por: Sathaiah, Magesh, et al.
Publicado: (2011)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
por: Liu, Weilin, et al.
Publicado: (2020)

Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
por: Kowalsky, Stacy J., et al.
Publicado: (2018)

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
por: Yang, Min, et al.
Publicado: (2021)

Oncolytic Virus Promotes Tumor-Reactive Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Feist, Mathilde, et al.
Publicado: (2021)

The Combination of Immunosuppression and Carrier Cells Significantly Enhances the Efficacy of Oncolytic Poxvirus in the Pre-Immunized Host
por: Guo, Z. Sheng, et al.
Publicado: (2010)

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
por: Guo, Zong Sheng, et al.
Publicado: (2014)

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
por: Liu, Weilin, et al.
Publicado: (2022)

Oncolytic Viruses as Platform for Multimodal Cancer Therapeutics: A Promising Land
por: Guo, Z. Sheng, et al.
Publicado: (2014)

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
por: Guo, Zong Sheng, et al.
Publicado: (2017)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy
por: Giehl, Esther, et al.
Publicado: (2021)

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
por: Downs-Canner, Stephanie, et al.
Publicado: (2016)

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
por: Ge, Yan, et al.
Publicado: (2020)

Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue II
por: Guo, Zong-Sheng
Publicado: (2021)

A cautionary note on the selectivity of oncolytic poxviruses
por: Tang, Bingtao, et al.
Publicado: (2019)

Oncolytic immunotherapy for metastatic cancer: lessons and future strategies
por: Guo, Zong-Sheng
Publicado: (2020)

A Fatal Case of Nafcillin-Induced Hepatotoxicity: A Case Report and the Literature Review
por: Alam, Mian Bilal, et al.
Publicado: (2012)

Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation
por: Chen, Lingjuan, et al.
Publicado: (2021)

Oncolytic Viruses as Anticancer Vaccines
por: Woller, Norman, et al.
Publicado: (2014)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
por: Truong, Cao-Sang, et al.
Publicado: (2022)

Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
por: Guo, Zong Sheng, et al.
Publicado: (2020)

Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
por: Ekeke, Chigozirim N., et al.
Publicado: (2021)

The Oncolytic Virus in Cancer Diagnosis and Treatment
por: Cao, Guo-dong, et al.
Publicado: (2020)

Oncolytic Viruses: Therapeutics With an Identity Crisis
por: Breitbach, Caroline J., et al.
Publicado: (2016)

Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
por: Shen, Zhen, et al.
Publicado: (2023)

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
por: Zhu, Zhi, et al.
Publicado: (2022)

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
por: Liu, Zuqiang, et al.
Publicado: (2018)

Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics
por: Peters, Cole, et al.
Publicado: (2016)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018)

Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective
por: Garmaroudi, Ghazal Asadi, et al.
Publicado: (2022)

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
por: Varela-Guruceaga, Maider, et al.
Publicado: (2018)

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
por: Davola, Maria Eugenia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bgtjn9ap94v0pf6s65jnvg7jcl